These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36560540)

  • 41. Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model.
    Rosu ME; Kok A; Bestebroer TM; de Meulder D; Verveer EP; Pronk MR; Dekker LJM; Luider TM; Richard M; van den Brand JMA; Fouchier RAM; Herfst S
    J Virol; 2022 Mar; 96(6):e0195921. PubMed ID: 35107371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
    Bodewes R; Kreijtz JH; Hillaire ML; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Gen Virol; 2010 Jul; 91(Pt 7):1743-53. PubMed ID: 20335492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model.
    Jang YH; Kim JY; Byun YH; Son A; Lee JY; Lee YJ; Chang J; Seong BL
    Front Immunol; 2018; 9():116. PubMed ID: 29449842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pilot-scale production of inactivated monoglycosylated split H
    Wu CY; Kao SE; Tseng YC; Lin YP; Hou JT; Wu LY; Chiu S; Ma CA; Hsiao PW; Hsiao J; Chen JR
    Antiviral Res; 2023 Aug; 216():105640. PubMed ID: 37263355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection.
    Kang HJ; Chu KB; Yoon KW; Eom GD; Mao J; Kim MJ; Lee SH; Moon EK; Quan FS
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
    Hessel A; Schwendinger M; Fritz D; Coulibaly S; Holzer GW; Sabarth N; Kistner O; Wodal W; Kerschbaum A; Savidis-Dacho H; Crowe BA; Kreil TR; Barrett PN; Falkner FG
    PLoS One; 2010 Aug; 5(8):e12217. PubMed ID: 20808939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge.
    Boravleva EY; Lunitsin AV; Kaplun AP; Bykova NV; Krasilnikov IV; Gambaryan AS
    Biochemistry (Mosc); 2020 May; 85(5):553-566. PubMed ID: 32571185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.
    Lo CY; Misplon JA; Li X; Price GE; Ye Z; Epstein SL
    Vaccine; 2021 Jul; 39(33):4628-4640. PubMed ID: 34226103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice.
    Dong C; Ma Y; Zhu W; Wang Y; Kim J; Wei L; Gill HS; Kang SM; Wang BZ
    Vaccine; 2024 Jan; 42(2):111-119. PubMed ID: 38097456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
    Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Kim KH; Jung YJ; Lee Y; Park BR; Oh J; Lee YN; Kim MC; Jeeva S; Kang SM
    Virology; 2020 Nov; 550():51-60. PubMed ID: 32882637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.
    Florek KR; Kamlangdee A; Mutschler JP; Kingstad-Bakke B; Schultz-Darken N; Broman KW; Osorio JE; Friedrich TC
    PLoS One; 2017; 12(8):e0181738. PubMed ID: 28771513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
    Powell TJ; Rijal P; McEwen-Smith RM; Byun H; Hardwick M; Schimanski LM; Huang KA; Daniels RS; Townsend ARM
    J Gen Virol; 2019 Mar; 100(3):431-445. PubMed ID: 30714896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice.
    Joe PT; Christopoulou I; van Hoecke L; Schepens B; Ysenbaert T; Heirman C; Thielemans K; Saelens X; Aerts JL
    J Transl Med; 2019 Jul; 17(1):242. PubMed ID: 31345237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice.
    Kim EH; Lee JH; Pascua PN; Song MS; Baek YH; Kwon HI; Park SJ; Lim GJ; Decano A; Chowdhury MY; Seo SK; Song MK; Kim CJ; Choi YK
    Virol J; 2013 Apr; 10():104. PubMed ID: 23551908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.